Growth Metrics

GeneDx Holdings (WGSWW) Total Current Liabilities (2020 - 2025)

GeneDx Holdings has reported Total Current Liabilities over the past 6 years, most recently at $108.9 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $108.9 million for Q4 2025, up 98.68% from a year ago — trailing twelve months through Dec 2025 was $108.9 million (up 98.68% YoY), and the annual figure for FY2025 was $108.9 million, up 98.68%.
  • Total Current Liabilities for Q4 2025 was $108.9 million at GeneDx Holdings, up from $87.6 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for WGSWW hit a ceiling of $204.6 million in Q2 2022 and a floor of $50.7 million in Q1 2024.
  • Median Total Current Liabilities over the past 5 years was $75.0 million (2021), compared with a mean of $92.3 million.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 161372.03% in 2021 and later tumbled 59.24% in 2023.
  • GeneDx Holdings' Total Current Liabilities stood at $101.3 million in 2021, then skyrocketed by 42.47% to $144.3 million in 2022, then tumbled by 59.24% to $58.8 million in 2023, then fell by 6.8% to $54.8 million in 2024, then surged by 98.68% to $108.9 million in 2025.
  • The last three reported values for Total Current Liabilities were $108.9 million (Q4 2025), $87.6 million (Q3 2025), and $71.4 million (Q2 2025) per Business Quant data.